Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Cantor Fitzgerald
Julphar
US Army
Citi
Boehringer Ingelheim
Farmers Insurance
Healthtrust
Deloitte
Fuji

Generated: October 20, 2017

DrugPatentWatch Database Preview

AZATHIOPRINE Drug Profile

« Back to Dashboard

What is the patent landscape for Azathioprine, and what generic Azathioprine alternatives are available?

Azathioprine is a drug marketed by Zydus Pharms Usa, Mylan, Amneal Pharms Llc, and West-ward Pharms Int. and is included in four NDAs.

The generic ingredient in AZATHIOPRINE is azathioprine sodium. There are fourteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the azathioprine sodium profile page.

Summary for Tradename: AZATHIOPRINE

US Patents:0
Applicants:4
NDAs:4
Suppliers / Packagers: see list15
Bulk Api Vendors: see list74
Clinical Trials: see list229
Patent Applications: see list8,927
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:AZATHIOPRINE at DailyMed

Pharmacology for Tradename: AZATHIOPRINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zydus Pharms Usa
AZATHIOPRINE
azathioprine
TABLET;ORAL077621-002Sep 5, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
West-ward Pharms Int
AZATHIOPRINE SODIUM
azathioprine sodium
INJECTABLE;INJECTION074419-001Mar 31, 1995RXNoYes► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa
AZATHIOPRINE
azathioprine
TABLET;ORAL077621-004Sep 5, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa
AZATHIOPRINE
azathioprine
TABLET;ORAL077621-001Mar 15, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa
AZATHIOPRINE
azathioprine
TABLET;ORAL077621-003Sep 5, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
Amneal Pharms Llc
AZATHIOPRINE
azathioprine
TABLET;ORAL074069-001Feb 16, 1996ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan
AZATHIOPRINE
azathioprine
TABLET;ORAL075568-001Dec 13, 1999ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Express Scripts
Cipla
McKesson
Cantor Fitzgerald
Johnson and Johnson
US Department of Justice
Deloitte
Healthtrust
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot